2012
DOI: 10.1007/s13671-012-0016-8
|View full text |Cite
|
Sign up to set email alerts
|

Severity Assessment and Outcome Measures in Acne Vulgaris

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
8
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 30 publications
0
8
0
Order By: Relevance
“…There are many tools to assess acne severity, but none of them considered as a universally accepted one. 19,20 Furthermore, they are not interchangeable as they do not measure the same components of the disease. Measuring disease severity is essential for clinical practice in terms of evaluation and follow-ups, and in comparing studies in the literature.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There are many tools to assess acne severity, but none of them considered as a universally accepted one. 19,20 Furthermore, they are not interchangeable as they do not measure the same components of the disease. Measuring disease severity is essential for clinical practice in terms of evaluation and follow-ups, and in comparing studies in the literature.…”
Section: Discussionmentioning
confidence: 99%
“…The mean score for CADI was (4.52 ± 2.919), and DLQI was (3.78 ± 4.17). For the DLQI, the majority of study population acne has either no effect (19,35.2%) or only a small effect (22, 40.7%) on patient life. Similarly, the majority of study population acne caused mild impairment of quality of life (34, 63%) or moderate impairment (14, 25.9%), as shown in Table 2.…”
Section: Cadi and Dlqimentioning
confidence: 97%
“…3 In clinical trials investigating acne treatments, multiple outcome measures have been used with no established standards. 4,5 This multiplicity, heterogeneity and lack of quality have been problematic in data synthesis by impeding comparative outcomes research and contributing to resource wastage. An international consensus on a core outcome set for clinical trials in acne could address this unmet need by standardizing and harmonizing existing outcome measures, and identifying those that might be lacking.…”
mentioning
confidence: 99%
“…In clinical trials investigating acne treatments, multiple outcome measures have been used with no established standards 4,5 . This multiplicity, heterogeneity and lack of quality have been problematic in data synthesis by impeding comparative outcomes research and contributing to resource wastage.…”
mentioning
confidence: 99%
“…Various global assessments are used to assess acne severity in clinical trials, including the Evaluator’s Global Severity Score (EGSS), Investigator’s Global Assessment (IGA), and Global Acne Assessment Score (GAAS), with ratings ranging from ‘clear’ to ‘severe’ or ‘very severe’ [ 40 ]. Similarly subjective scales have also been used to assess hyperpigmentation, such as an adaptation of IGA with scores/ratings ranging from 0 = ‘clear of hyperpigmentation’ to 5 = ‘very severe hyperpigmentation (very dark brown, almost black in quality)’ [ 41 ] and a cutaneous safety instrument (used in acne clinical trials) that includes a hyperpigmentation item with scores/ratings ranging from 0 = ‘none, no evidence’ to 3 = ‘severe, marked/prominent’ [ 37 ].…”
Section: Assessing Acne and Hyperpigmentation In Patients With Skin Of Color (Soc)mentioning
confidence: 99%